Treatment of end - stage liver disease in the jsc national scientific center for oncology and transplantology, Astana: views and perspectives

Loading...
Thumbnail Image

Authors

Yesmembetov, K.
Kaliaskarova, K.
Muratova, Zh.
Borovskiy, S.
Sultanaliyev, T.
Mukazhanov, A.
Zharkimbekov, B.
Zhexembayev, A.
Kuttymuratov, G.
Amanzholov, B.

Journal Title

Journal ISSN

Volume Title

Publisher

National Laboratory Astana, Nazarbayev University 2016

Abstract

End-stage liver disease represents a major healthcare problem worldwide and in Kazakhstan, carrying a high risk for mortality. Around 1000 patients with end-stage liver disease need liver transplantation in Kazakhstan, more than 50 of them dying yearly without being transplanted.

Description

Citation

Yesmembetov, K., Kaliaskarova, K., Muratova, Zh., Borovskiy, S., Sultanaliyev, T., Mukazhanov, A., Zharkimbekov, B., Zhexembayev, A., Kuttymuratov, G., Amanzholov, B. 2016. Treatment of end - stage liver disease in the jsc national scientific center for oncology and transplantology, Astana: views and perspectives. Abstract book. 4 th International Scientific Conference. “Regenerative medicine & healthy aging”. National Laboratory Astana, Nazarbayev University. http://nur.nu.edu.kz/handle/123456789/1522.

Collections

Endorsement

Review

Supplemented By

Referenced By

Creative Commons license

Except where otherwised noted, this item's license is described as Attribution-NonCommercial-ShareAlike 3.0 United States